PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors.

[1]  A. Feeney,et al.  Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. , 1996, The EMBO journal.

[2]  A. Brass,et al.  Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1. , 1996, Genes & development.

[3]  F. Alt,et al.  The T Cell Leukemia Oncoprotein SCL/tal-1 Is Essential for Development of All Hematopoietic Lineages , 1996, Cell.

[4]  S. Orkin,et al.  The transcriptional control of hematopoiesis. , 1996, Blood.

[5]  Harinder Singh,et al.  Gene targeting reveals a hierarchy of transcription factors regulating specification of lymphoid cell fates. , 1996, Current opinion in immunology.

[6]  J. Downing,et al.  AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis , 1996, Cell.

[7]  E. Scott,et al.  PU. 1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation. , 1995, Immunity.

[8]  I. Weissman,et al.  The purification and characterization of fetal liver hematopoietic stem cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[9]  D. Tenen,et al.  PU.1 (Spi-1) autoregulates its expression in myeloid cells. , 1995, Oncogene.

[10]  C. Begley,et al.  Absence of yolk sac hematopoiesis from mice with a targeted disruption of the scl gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[11]  S. Orkin,et al.  Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal-1/SCL , 1995, Nature.

[12]  F. Moreau-Gachelin.  Spi-1/PU.1: an oncogene of the Ets family. , 1994, Biochimica et biophysica acta.

[13]  E. Wagner,et al.  Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5 BSAP , 1994, Cell.

[14]  I. Weissman,et al.  The long-term repopulating subset of hematopoietic stem cells is deterministic and isolatable by phenotype. , 1994, Immunity.

[15]  A. Sharpe,et al.  The ikaros gene is required for the development of all lymphoid lineages , 1994, Cell.

[16]  Stuart H. Orkin,et al.  An early haematopoietic defect in mice lacking the transcription factor GATA-2 , 1994, Nature.

[17]  E. Scott,et al.  Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. , 1994, Science.

[18]  M. Evans,et al.  The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development , 1994, Cell.

[19]  M. Klemsz,et al.  Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1. , 1993, Blood.

[20]  R. Auerbach,et al.  Identification and characterization of hematopoietic stem cells from the yolk sac of the early mouse embryo. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[21]  V. Stewart,et al.  Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. , 1993, Science.

[22]  M. Ogawa,et al.  Differentiation and proliferation of hematopoietic stem cells. , 1993, Blood.

[23]  D. Housman,et al.  Mouse beta-globin DNA-binding protein B1 is identical to a proto-oncogene, the transcription factor Spi-1/PU.1, and is restricted in expression to hematopoietic cells and the testis , 1993, Molecular and cellular biology.

[24]  A. Cumano,et al.  Bipotential precursors of B cells and macrophages in murine fetal liver , 1992, Nature.

[25]  A. Cumano,et al.  Enrichment and characterization of uncommitted B‐cell precursors from fetal liver at day 12 of gestation. , 1992, The EMBO journal.

[26]  S. Swerdlow,et al.  A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis , 1991, Cell.

[27]  I. Lemischka,et al.  Cellular and developmental properties of fetal hematopoietic stem cells , 1990, Cell.

[28]  C. Baum,et al.  Cell surface antigens expressed by subsets of pre-B cells and B cells. , 1984, Journal of immunology.

[29]  J. B. WhitneyIII.  Simplified typing of mouse hemoglobin (Hbb) phenotypes using cystamine , 1978 .

[30]  G. Spangrude.  Biological and clinical aspects of hematopoietic stem cells. , 1994, Annual review of medicine.

[31]  I. Weissman,et al.  Heterogeneity of hematopoietic stem cells. , 1993, Current opinion in immunology.

[32]  A. Joyner,et al.  Production of chimeras and genetically defined offspring from targeted ES cells. , 1993 .

[33]  M. Tavassoli.  Embryonic and fetal hemopoiesis: an overview. , 1991, Blood cells.